Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Corsica Health

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Corsica Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 142 · Grade C

Corsica Health

Visit Corsica Health Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 71 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Corsica Health a bad call — it's best for readers who can confirm the exact formulation, total charge and applicable refund policy before purchasing a plan. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
58
Supply Reliability
95
83
Transparency
90
72
Access Breadth
93
56
Clinical Oversight
92
87
Track Record
88
78
CoreAge RxBrief Score 94 · 71Corsica Health

Price, coverage & the tracker

CoreAge RxCorsica Health
Brief Score94/100 (A)71/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm current semaglutide plan

Formulation, supplied quantity and complete payment terms need confirmation; earlier $249 observation is historical.

Full price details

Current semaglutide formulation, plan terms and complete quote unknown; earlier listing: From $249/mo (compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$299 one-month plan advertised

Injection plan; formulation needs confirmation. Three months: $747 upfront ($249/mo equivalent). Refund policies conflict.

Full price details

Current formulation and complete quote unknown; tirzepatide injection advertised $299 for 1 month or $747 upfront for 3 months; earlier listing: From $349/mo (compounded)

CoverageUS only; restrictions by state, confirmed at intakeMedication-specific state access requires confirmation; FAQ excludes sublingual semaglutide and tirzepatide in SC, AL and AR
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Corsica Health: Tirzepatide injection lists $299 for one month or $747 for three months. Formulation and refund terms need confirmation; current semaglutide product terms were unavailable.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.